334 related articles for article (PubMed ID: 25375801)
21. Apelin and its receptor are expressed in human osteoblasts.
Xie H; Tang SY; Cui RR; Huang J; Ren XH; Yuan LQ; Lu Y; Yang M; Zhou HD; Wu XP; Luo XH; Liao EY
Regul Pept; 2006 May; 134(2-3):118-25. PubMed ID: 16563531
[TBL] [Abstract][Full Text] [Related]
22. Possible involvement of downregulation of the apelin-APJ system in doxorubicin-induced cardiotoxicity.
Hamada J; Baasanjav A; Ono N; Murata K; Kako K; Ishida J; Fukamizu A
Am J Physiol Heart Circ Physiol; 2015 Apr; 308(8):H931-41. PubMed ID: 25681427
[TBL] [Abstract][Full Text] [Related]
23. Apelin/APJ System: A Novel Therapeutic Target for Myocardial Ischemia/Reperfusion Injury.
Chen Z; Wu D; Li L; Chen L
DNA Cell Biol; 2016 Dec; 35(12):766-775. PubMed ID: 27854125
[TBL] [Abstract][Full Text] [Related]
24. Apelin ameliorates TNF-α-induced reduction of glycogen synthesis in the hepatocytes through G protein-coupled receptor APJ.
Chu J; Zhang H; Huang X; Lin Y; Shen T; Chen B; Man Y; Wang S; Li J
PLoS One; 2013; 8(2):e57231. PubMed ID: 23437347
[TBL] [Abstract][Full Text] [Related]
25. Gαi-biased apelin analog protects against isoproterenol-induced myocardial dysfunction in rats.
Coquerel D; Delile E; Dumont L; Chagnon F; Murza A; Sainsily X; Salvail D; Sarret P; Marsault E; Auger-Messier M; Lesur O
Am J Physiol Heart Circ Physiol; 2021 Apr; 320(4):H1646-H1656. PubMed ID: 33635165
[TBL] [Abstract][Full Text] [Related]
26. Involvement of the apelin receptor APJ in Fas-induced liver injury.
Yasuzaki H; Yoshida S; Hashimoto T; Shibata W; Inamori M; Toya Y; Tamura K; Maeda S; Umemura S
Liver Int; 2013 Jan; 33(1):118-26. PubMed ID: 23121371
[TBL] [Abstract][Full Text] [Related]
27. Apelin/APJ system: an emerging therapeutic target for respiratory diseases.
Yan J; Wang A; Cao J; Chen L
Cell Mol Life Sci; 2020 Aug; 77(15):2919-2930. PubMed ID: 32128601
[TBL] [Abstract][Full Text] [Related]
28. Apelin-APJ induces ICAM-1, VCAM-1 and MCP-1 expression via NF-κB/JNK signal pathway in human umbilical vein endothelial cells.
Lu Y; Zhu X; Liang GX; Cui RR; Liu Y; Wu SS; Liang QH; Liu GY; Jiang Y; Liao XB; Xie H; Zhou HD; Wu XP; Yuan LQ; Liao EY
Amino Acids; 2012 Nov; 43(5):2125-36. PubMed ID: 22532031
[TBL] [Abstract][Full Text] [Related]
29. Non-activated APJ suppresses the angiotensin II type 1 receptor, whereas apelin-activated APJ acts conversely.
Sun X; Iida S; Yoshikawa A; Senbonmatsu R; Imanaka K; Maruyama K; Nishimura S; Inagami T; Senbonmatsu T
Hypertens Res; 2011 Jun; 34(6):701-6. PubMed ID: 21412239
[TBL] [Abstract][Full Text] [Related]
30. Apelin/APJ system and cancer.
Yang Y; Lv SY; Ye W; Zhang L
Clin Chim Acta; 2016 Jun; 457():112-6. PubMed ID: 27083318
[TBL] [Abstract][Full Text] [Related]
31. Apelin protects myocardial injury induced by isoproterenol in rats.
Jia YX; Pan CS; Zhang J; Geng B; Zhao J; Gerns H; Yang J; Chang JK; Tang CS; Qi YF
Regul Pept; 2006 Jan; 133(1-3):147-54. PubMed ID: 16278022
[TBL] [Abstract][Full Text] [Related]
32. G protein-coupled APJ receptor signaling induces focal adhesion formation and cell motility.
Hashimoto Y; Ishida J; Yamamoto R; Fujiwara K; Asada S; Kasuya Y; Mochizuki N; Fukamizu A
Int J Mol Med; 2005 Nov; 16(5):787-92. PubMed ID: 16211245
[TBL] [Abstract][Full Text] [Related]
33. Requirement of apelin-apelin receptor system for oxidative stress-linked atherosclerosis.
Hashimoto T; Kihara M; Imai N; Yoshida S; Shimoyamada H; Yasuzaki H; Ishida J; Toya Y; Kiuchi Y; Hirawa N; Tamura K; Yazawa T; Kitamura H; Fukamizu A; Umemura S
Am J Pathol; 2007 Nov; 171(5):1705-12. PubMed ID: 17884970
[TBL] [Abstract][Full Text] [Related]
34. Structural and functional study of the apelin-13 peptide, an endogenous ligand of the HIV-1 coreceptor, APJ.
Fan X; Zhou N; Zhang X; Mukhtar M; Lu Z; Fang J; DuBois GC; Pomerantz RJ
Biochemistry; 2003 Sep; 42(34):10163-8. PubMed ID: 12939143
[TBL] [Abstract][Full Text] [Related]
35. Apelin suppresses apoptosis of human vascular smooth muscle cells via APJ/PI3-K/Akt signaling pathways.
Cui RR; Mao DA; Yi L; Wang C; Zhang XX; Xie H; Wu XP; Liao XB; Zhou H; Meng JC; Yuan LQ; Liao EY
Amino Acids; 2010 Nov; 39(5):1193-200. PubMed ID: 20495838
[TBL] [Abstract][Full Text] [Related]
36. The apelin-APJ system in heart failure: pathophysiologic relevance and therapeutic potential.
Japp AG; Newby DE
Biochem Pharmacol; 2008 May; 75(10):1882-92. PubMed ID: 18272138
[TBL] [Abstract][Full Text] [Related]
37. Central and peripheral apelin receptor distribution in the mouse: species differences with rat.
Pope GR; Roberts EM; Lolait SJ; O'Carroll AM
Peptides; 2012 Jan; 33(1):139-48. PubMed ID: 22197493
[TBL] [Abstract][Full Text] [Related]
38. Heterodimerization of human apelin and bradykinin 1 receptors: novel signal transduction characteristics.
Bai B; Liu L; Zhang N; Wang C; Jiang Y; Chen J
Cell Signal; 2014 Jul; 26(7):1549-59. PubMed ID: 24686079
[TBL] [Abstract][Full Text] [Related]
39. Distribution of mRNA encoding B78/apj, the rat homologue of the human APJ receptor, and its endogenous ligand apelin in brain and peripheral tissues.
O'Carroll AM; Selby TL; Palkovits M; Lolait SJ
Biochim Biophys Acta; 2000 Jun; 1492(1):72-80. PubMed ID: 11004481
[TBL] [Abstract][Full Text] [Related]
40. Laser-induced choroidal neovascularization in mice attenuated by deficiency in the apelin-APJ system.
Hara C; Kasai A; Gomi F; Satooka T; Sakimoto S; Nakai K; Yoshioka Y; Yamamuro A; Maeda S; Nishida K
Invest Ophthalmol Vis Sci; 2013 Jun; 54(6):4321-9. PubMed ID: 23722395
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
